Learn more →
Back to Expert Scholars
Immunotherapy / 免疫治疗Cancer Immunology

Robert D. Schreiber

罗伯特·施赖贝尔

PhD

🏢Washington University School of Medicine in St. Louis(圣路易斯华盛顿大学医学院)🌐USA

Alumni Endowed Professor of Pathology and Immunology; Director, Center for Human Immunology and Immunotherapy Programs病理学与免疫学终身讲席教授;人类免疫学与免疫治疗项目中心主任

105
h-index
2
Key Papers
5
Awards
3
Key Contributions

👥Biography 个人简介

Robert Schreiber is a pioneer of cancer immunology at Washington University St. Louis. He formulated the cancer immunoediting hypothesis—encompassing elimination, equilibrium, and escape—fundamentally redefining how the immune system shapes tumor evolution. His work on IFN-gamma and immunosurveillance underpins modern checkpoint immunotherapy.

Share:

🧪Research Fields 研究领域

Cancer Immunoediting癌症免疫编辑
Cancer Immunosurveillance癌症免疫监视
IFN-gamma SignalingIFN-γ信号传导
Tumor Neoantigens肿瘤新抗原
Innate and Adaptive Immunity先天与适应性免疫

🎓Key Contributions 主要贡献

Cancer Immunoediting Theory

Developed the three-phase cancer immunoediting model (elimination, equilibrium, escape) with Lloyd Old, providing the foundational framework explaining how immune pressure both restrains tumors and selects for immune-evasive variants, published in Nature 2004.

IFN-gamma in Tumor Immunosurveillance

Demonstrated through gene-targeted mouse models that IFN-gamma receptor signaling on tumor cells is essential for immune-mediated tumor rejection, establishing IFN-gamma as a critical mediator of cancer immunosurveillance.

Neoantigen-Based Immunotherapy

Pioneered personalized neoantigen vaccine strategies, showing that mutation-derived neoantigens are primary targets of tumor-specific T cells and can be exploited therapeutically to overcome immune escape.

Representative Works 代表性著作

[1]

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Science (2011)

Landmark review synthesizing the cancer immunoediting framework and its mechanistic basis, which became a cornerstone reference for the checkpoint immunotherapy era.

[2]

Immunological Editing of Cancer

Nature (2004)

Original article establishing the three-phase cancer immunoediting model with experimental evidence from IFN-gamma-deficient and RAG-deficient mouse systems.

🏆Awards & Recognition 奖项与荣誉

🏆AACR-William B. Coley Award for Distinguished Research in Basic Immunology
🏆American Association of Immunologists Lifetime Achievement Award
🏆NCI Outstanding Investigator Award
🏆Member, National Academy of Sciences
🏆Member, American Academy of Arts and Sciences

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 罗伯特·施赖贝尔 的研究动态

Follow Robert D. Schreiber's research updates

留下邮箱,当我们发布与 Robert D. Schreiber(Washington University School of Medicine in St. Louis)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment